Category Archives: Technology and Society

After Keystone

“We’d rather sell our oil to China.”

What Harper is saying is that Canada could make more money by creating a market for its oil rather than selling all of it solely to the US. In other words, the cost of Canadian oil will go up as the US is forced to compete with China.

…Obama could have approved the pipeline, added 30,000 jobs to the economy, and insured the most secure oil source for our future. Instead, he chose to kill the pipeline and the jobs and, in the process, insured that America will pay more for the oil it does buy. It’s hard to imagine a worse decision, especially since it was all so Obama could deny Republicans a win in the run-up to the next election.

It’s worse, actually, considering the latest news:

Officials in the White House’s Office of Management and Budget told the Treasury Department that the announcement of a conditional commitment to Solyndra was imminent. The department had one day to review the terms of the guarantee to accommodate an Energy Department press release.

“Treasury’s consultative role was not sufficiently defined, the consultation that did occur was rushed and no documentation was retained as to how Treasury’s serious concerns with the loan were addressed,” the audit said.

…The Treasury requested more time for review and later agreed with the Energy Department’s request to expedite the review by March 19, 2009, “so that the press release could be issued on the morning of March 20, 2009,” according to the report.

Got that? A speculative “green” energy project that in retrospect, once the rest of us saw the details, was obviously going to be a business disaster, and ended up costing the taxpayers over half a billion dollars, was approved after a “one-day review.” Yet the president demanded that Keystone, a project with certain and vast energy output, be delayed for many more months so that it could be “adequately reviewed,” despite the fact that it had already had years of review. And as a result our energy prices will now rise in the future, with no way of returning to the status quo. Just as the president told us he wanted them to when he ran four years ago.

The campaign ad this fall almost writes itself. Or themselves.

One wonders what administration defenders are thinking as they watch this ongoing trainwreck. We know what they’re saying, but what are they thinking?

A Breakthrough?

A single anti-body that shrinks a wide variety of human tumors in mice.

They showed that nearly every human cancer cell they examined expressed CD47 — usually at higher levels (on average, about three times more) than did non-cancerous cells. Furthermore, people whose cancer cells express a lot of CD47 tend to have shorter life spans than people with similar cancers that express less CD47. This suggests that an analysis of the levels of CD47 expression in some types of tumors could be a valuable prognostic tool for patients and their doctors.

Willingham and Volkmer then implanted the different human tumor cells into matching locations in the bodies of mice — breast cancer tumors into the mammary fat pads, and ovarian cancer tumors into the abdomen, for example. Once the tumors were well-established (after two weeks or more), they treated the animals with the anti-CD47 antibody.

The researchers saw that most of the established tumors begin to shrink and even, in some cases, disappear within weeks of treatment with the antibody. In one case, antibody treatment cured five mice injected with the same human breast cancer cells. When the tumor was gone, the treatment was discontinued; the mice were monitored for four months with no signs of recurrence.

“These results indicate that anti-CD47 antibodies can dramatically inhibit the growth of human solid tumors by blocking the ability of CD47 to transmit the ‘don’t-eat-me’ signal to macrophages,” concluded the authors.

Clinical trials for humans within two years?

Faster, please.